(Q33741316)

English

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

object named as

Donald F Smee

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Diana Noah

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Colleen B. Jonsson

object named as

Colleen B Jonsson

3

1 reference

ORCID Public Data File 2021

author name string

Joseph A Maddry

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Xi Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Subramaniam Ananthan

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Judith Hobrath

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

James W Noah

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Xiaolin Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Fuli Jia

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinton Maddox

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Melinda I Sosa

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

E Lucile White

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

William E Severson

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Biomolecular Screening

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

73-81

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

H5N1 Virus Attachment to Lower Respiratory Tract

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

H5N1 influenza--continuing evolution and spread

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Eight-plasmid system for rapid generation of influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

HA-pseudotyped retroviral vectors for influenza antagonist screening

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Community-acquired bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

https://api.crossref.org/works/10.1177%2F1087057110384613

21 January 2018

Identifiers

10.1177/1087057110384613

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33741316&oldid=1967337764"